Safety and Efficacy of Empagliflozin in Hemodialysis
Abroad (travel likely)RecruitingPHASE2
Conditions
End Stage Renal Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Finnian R. Mc Causland)NYU Langone Health, New York, New York, United States
Contact: Principal Investigator (David M Charytan, MS, MSc)
Study leads
David Charytan, MS, MSc
Principal Investigator
NYU Langone Health